Gemcitabine (Gem) and nab-paclitaxel (NP) ± nivolumab (nivo) ± CD40 agonistic monoclonal antibody APX005M (sotigalimab), in patients (Pts) with untreated metastatic pancreatic adenocarcinoma (mPDAC): Phase (Ph) 2 final results.

被引：17
|
作者：
O'Hara, Mark H.
O'Reilly, Eileen Mary
Wolff, Robert A.
Wainberg, Zev A.
Ko, Andrew H.
Rahma, Osama E.
Fisher, George A.
Lyman, Jaclyn Paige
Cabanski, Christopher R.
Karakunnel, Joyson Joseph
Gherardini, Pier Federico
Kitch, Lacey J.
Bucktrout, Samantha
Christopher, Elizabeth
Mick, Rosemarie
Chen, Richard
Trifan, Ovidiu C.
Salvador, Lisa
O'Donnell-Tormey, Jill
Vonderheide, Robert H.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.4019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4019
引用
收藏
页数：3
相关论文
共 29 条
  • [21] Phase III study (daNIS-2) of the anti-TGF-ß monoclonal antibody (mAb) NIS793 with nab-paclitaxel/gemcitabine (NG) versus NG alone in patients (pts) with first-line metastatic pancreatic ductal adenocarcinoma (mPDAC)
    O'Reilly, Eileen Mary
    Golan, Talia
    Ikeda, Masafumi
    Milella, Michele
    Taieb, Julien
    Wainberg, Zev A.
    Wang, Li-Wei
    Gyambibi, Nana
    Lopez-Martin, Eva Maria
    Xu, Kun
    Macarulla, Teresa
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [22] Phase I/II dose escalation and expansion cohort safety and efficacy study of image guided intratumoral CD40 agonistic monoclonal antibody APX005M in combination with systemic pembrolizumab for treatment naive metastatic melanoma.
    Johnson, Daniel H.
    Bentebibel, Salah E.
    Lecagoonporn, Srisuda
    Bernatchez, Chantale
    Haymaker, Cara L.
    Murthy, Ravi
    Tam, Alda
    Yee, Cassian
    Amaria, Rodabe Navroze
    Patel, Sapna Pradyuman
    Tawbi, Hussein Abdul-Hassan
    Glitza, Isabella Claudia
    Davies, Michael A.
    Hwu, Wen-Jen
    Hwu, Patrick
    Overwijk, Willem W.
    Diab, Adi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [23] Phase Ib of anticancer stem cell antibody OMP-59R5 (anti-Notch2/3) in combination with nab-paclitaxel and gemcitabine (Nab-P plus Gem) in patients (pts) with untreated metastatic pancreatic cancer (mPC)
    O'Reilly, Eileen Mary
    Smith, Lon S.
    Bendell, Johanna C.
    Rangwala, Fatima A.
    Schmidt, William
    Stephenson, Joe
    Kapoun, Ann
    Xu, Lu
    Hill, Dawn
    Zhou, Lei
    Dupont, Jakob
    Cohn, Allen Lee
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [24] PHASE 1 STUDY OF THE CD40 AGONISTIC MONOCLONAL ANTIBODY APX005M (SOTIGALIMAB) IN PEDIATRIC, ADOLESCENT, AND YOUNG ADULT PATIENTS WITH RECURRENT OR PROGRESSIVE CNS TUMORS AND NEWLY DIAGNOSED BRAIN STEM GLIOMA: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY (PBTC-051; NCT03389802)
    Lindsay, Holly B.
    Billups, Catherine
    Baxter, Patricia
    Hwang, Eugene
    Lenzen, Alicia
    MacDonald, Tobey
    Pollack, Ian F.
    Robison, Nathan
    Vinitsky, Anna
    Poussaint, Tina Young
    Onar-Thomas, Arzu
    Fangusaro, Jason
    Dunkel, Ira J.
    NEURO-ONCOLOGY, 2024, 26
  • [25] Results of a randomized phase II trial of an anti-notch 2/3, tarextumab (OMP-59R5, TRXT, anti-Notch2/3), in combination with nab-paclitaxel and gemcitabine (Nab-P plus Gem) in patients (pts) with untreated metastatic pancreatic cancer (mPC).
    O'Reilly, Eileen Mary
    Sahai, Vaibhav
    Bendell, Johanna C.
    Bullock, Andrea J.
    LoConte, Noelle K.
    Hatoum, Hassan
    Ritch, Paul S.
    Hool, Hugo
    Leach, Joseph W.
    Sanchez, James
    Sohal, Davendra
    Strickler, John H.
    Patel, Ravindranath
    Wang-Gillam, Andrea
    Firdaus, Irfan
    Kapoun, Ann M.
    Holmgren, Eric
    Zhou, Lei
    Dupont, Jakob
    Picozzi, Vincent J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [26] Phase II study (daNIS-1) of the anti-TGF-β monoclonal antibody (mAb) NIS793+/- spartalizumab in combination with nab-paclitaxel/gemcitabine (NG) versus NG alone in patients with first-line metastatic pancreatic ductal adenocarcinoma (mPDAC)
    Sivakumar, S.
    Macarulla, T.
    Grell, P.
    Chee, C.
    Krishnamurthy, A.
    Wong, M. Ka
    Michael, M.
    Milella, M.
    Prager, G.
    Springfeld, C.
    Collignon, J.
    Siveke, J.
    Santoro, A.
    Lin, C.
    Peltola, K.
    Bostel, G.
    Jankovic, D.
    Altzerinakou, M.
    Fabre, C.
    Bai, L.
    ANNALS OF ONCOLOGY, 2022, 33 : S247 - S247
  • [27] Biomarker analysis in Phase 1b study of anti-cancer stem cell antibody Tarextumab (TAR) in combination with nab-paclitaxel and gemcitabine (Nab-P plus Gem) demonstrates pharmacodynamic (PD) modulation of the Notch pathway in patients (pts) with untreated metastatic pancreatic cancer (mPC)
    Kapoun, A.
    O'Reilly, E.
    Cohn, A.
    Bendell, J. C.
    Smith, L.
    Strickler, J. H.
    Gluck, W.
    Liu, Y. W.
    Wallace, B.
    Tam, R.
    Cancilla, B.
    Brunner, A.
    Hill, D.
    Zhou, L.
    Dupont, J.
    Zhang, C.
    Wang, M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 152 - 152
  • [28] Phase II study (daNIS-1) of the anti-TGF-b monoclonal antibody (mAb) NIS793 with and without the PD-1 inhibitor spartalizumab in combination with nab-paclitaxel/gemcitabine (NG) versus NG alone in patients (pts) with first-line metastatic pancreatic ductal adenocarcinoma (mPDAC).
    Bai, Li-Yuan
    Macarulla, Teresa
    Grell, Peter
    Chee, Cheng Ean
    Krishnamurthy, Anuradha
    Wong, Mark Ka
    Michael, Michael
    Milella, Michele
    Prager, Gerald
    Springfeld, Christoph
    Collignon, Joelle
    Siveke, Jens
    Santoro, Armando
    Lin, Chia-Chi
    Peltola, Katriina Johanna
    Bostel, Geraldine
    Jankovic, Dragana
    Altzerinakou, Maria-Athina
    Fabre, Claire
    Sivakumar, Shivan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : TPS761 - TPS761
  • [29] Phase II study (daNIS-1) of the anti-TGF-ß monoclonal antibody (mAb) NIS793 with and without the PD-1 inhibitor spartalizumab in combination with nab-paclitaxel/ gemcitabine (NG) versus NG alone in patients (pts) with first-line metastatic pancreatic ductal adenocarcinoma (mPDAC)
    Bai, Li-Yuan
    Macarulla, Teresa
    Grell, Peter
    Chee, Cheng Ean
    Krishnamurthy, Anuradha
    Wong, Mark Ka
    Michael, Michael
    Milella, Michele
    Prager, Gerald
    Springfeld, Christoph
    Collignon, Joelle
    Siveke, Jens
    Santoro, Armando
    Lin, Chia-Chi
    Peltola, Katriina Johanna
    Bostel, Geraldine
    Jankovic, Dragana
    Altzerinakou, Maria-Athina
    Fabre, Claire
    Sivakumar, Shivan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
123